CRS: JHU
Position: Co-investigator
CRS: BJMC
Position: Dean, BJ Medical College and India CRS PI
Position: Study Coordinator
Position: CRS Leader
Position: CTU Leader for HPTN Studies
Position: Site Leader
Position: Global Community Advisory Board Representative
CRS: BJMCJHU
Position: Principal Investigator, Johns Hopkins Professor of Medicine and Public Health; Deputy Director, CCGHE
Position: CRS Data Manager and Deputy Director
The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
